Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers

Clinical trial NCT02098954 · UNKNOWN

Trial details

NCT number: NCT02098954
Sponsor: Hunan Province Tumor Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small Cell Lung EGFR Gene Mutation

Start date: 2014-07-01
Primary completion: 2024-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.